Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 07 Jul 2026 for Monte Rosa Therapeutics, Inc., €114k.
Filing timeline
BuySaleSharon Townson
Insider track record
Disclosed buys
0
Disclosed sells
4
Signal history
Sharon Townson: trading record in brief
All filings by Sharon Townson on record concern Monte Rosa Therapeutics, Inc. In total, 8 filings cover trades dated from 2 January 2025 to 6 July 2026.
No open-market purchase appears, only 4 sales worth €216k. The rest of the record consists of 2 share grants and 2 option exercises. In 2026 alone, the filings show no purchases and 4 sales.
The latest filing, published on 7 July 2026, reports an open-market sale of €114k in Monte Rosa Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sharon Townson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
5,600 shares@ US$23.24950.013% mcap73.7% of flowCommon StockSEC:0001193125-26-297558:1
400 shares@ US$24.130.0010% mcap5.5% of flowCommon StockSEC:0001193125-26-297558:2
6,000 shares@ US$6.140.0037% mcap20.9% of flowCommon StockSEC:0001193125-26-297558:0
3,000 sharesCommon StockSEC:0001193125-26-282736:0
3,000 sharesCommon StockSEC:0001193125-26-282736:1
35,000 sharesCommon StockSEC:0001193125-26-002385:0
36,000 sharesCommon StockSEC:0000950170-25-002099:0
7 of 7 declarations
